Works matching IS 00070920 AND DT 2019 AND VI 120 AND IP 6

Results: 13

Prognostic value of serum alkaline phosphatase in spinal metastatic disease.

Published in:

2019

By:

Karhade, Aditya V.;
Thio, Quirina C. B. S.;
Kuverji, Megna;
Ogink, Paul T.;
Ferrone, Marco L.;
Schwab, Joseph H.

Publication type:

journal article

Intensified therapies improve survival and identification of novel prognostic factors for placental-site and epithelioid trophoblastic tumours.

Published in:

2019

By:

Froeling, Fieke E. M.;
Ramaswami, Ramya;
Papanastasopoulos, Panagiotis;
Kaur, Baljeet;
Sebire, Neil J.;
Short, Dee;
Fisher, Rosemary A.;
Sarwar, Naveed;
Wells, Michael;
Singh, Kam;
Ellis, Laura;
Horsman, Janet M.;
Winter, Matthew C.;
Tidy, John;
Hancock, Barry W.;
Seckl, Michael J.

Publication type:

journal article

Apelin and apelin receptor expression in renal cell carcinoma.

Published in:

2019

By:

Tolkach, Yuri;
Ellinger, Jörg;
Kremer, Anika;
Esser, Laura;
Müller, Stefan C.;
Stephan, Carsten;
Jung, Klaus;
Toma, Marieta;
Kristiansen, Glen;
Hauser, Stefan

Publication type:

journal article

MicroRNA-196a is regulated by ER and is a prognostic biomarker in ER+ breast cancer.

Published in:

2019

By:

Milevskiy, Michael J. G.;
Gujral, Udai;
Del Lama Marques, Carolina;
Stone, Andrew;
Northwood, Korinne;
Burke, Lez J.;
Gee, Julia M. W.;
Nephew, Kenneth;
Clark, Susan;
Brown, Melissa A.

Publication type:

journal article

Synergistic antitumour activity of HDAC inhibitor SAHA and EGFR inhibitor gefitinib in head and neck cancer: a key role for ΔNp63α.

Published in:

2019

By:

Citro, Simona;
Bellini, Alice;
Miccolo, Claudia;
Ghiani, Lavinia;
Carey, Thomas E.;
Chiocca, Susanna

Publication type:

journal article

Genome-wide association study of germline variants and breast cancer-specific mortality.

Published in:

2019

By:

Escala-Garcia, Maria;
Guo, Qi;
Dörk, Thilo;
Canisius, Sander;
Keeman, Renske;
Dennis, Joe;
Beesley, Jonathan;
Lecarpentier, Julie;
Bolla, Manjeet K.;
Wang, Qin;
Abraham, Jean;
Andrulis, Irene L.;
Anton-Culver, Hoda;
Arndt, Volker;
Auer, Paul L.;
Beckmann, Matthias W.;
Behrens, Sabine;
Benitez, Javier;
Bermisheva, Marina;
Bernstein, Leslie

Publication type:

journal article

Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours.

Published in:

2019

By:

Serrano, César;
Mariño-Enríquez, Adrián;
Tao, Derrick L.;
Ketzer, Julia;
Eilers, Grant;
Zhu, Meijun;
Yu, Channing;
Mannan, Aristotle M.;
Rubin, Brian P.;
Demetri, George D.;
Raut, Chandrajit P.;
Presnell, Ajia;
McKinley, Arin;
Heinrich, Michael C.;
Czaplinski, Jeffrey T.;
Sicinska, Ewa;
Bauer, Sebastian;
George, Suzanne;
Fletcher, Jonathan A.

Publication type:

journal article

Secondary KIT mutations: the GIST of drug resistance and sensitivity.

Published in:

2019

By:

Napolitano, Andrea;
Vincenzi, Bruno

Publication type:

Editorial

Predictive values of colorectal cancer alarm symptoms in the general population: a nationwide cohort study.

Published in:

2019

By:

Rasmussen, Sanne;
Haastrup, Peter Fentz;
Balasubramaniam, Kirubakaran;
Elnegaard, Sandra;
Christensen, René dePont;
Storsveen, Maria Munch;
Søndergaard, Jens;
Jarbøl, Dorte Ejg

Publication type:

journal article

Brivanib in combination with Notch3 silencing shows potent activity in tumour models.

Published in:

British Journal of Cancer, 2019, v. 120, n. 6, p. 601, doi. 10.1038/s41416-018-0375-4

By:

Giovannini, Catia;
Salzano, Anna Maria;
Baglioni, Michele;
Vitale, Monica;
Scaloni, Andrea;
Zambrano, Nicola;
Giannone, Ferdinando Antonio;
Vasuri, Francesco;
D'Errico, Antonia;
Svegliati Baroni, Gianluca;
Bolondi, Luigi;
Gramantieri, Laura

Publication type:

Article

Adult height in relation to risk of cancer in a cohort of 22,809,722 Korean adults.

Published in:

2019

By:

Choi, Yoon Jin;
Lee, Dong Ho;
Han, Kyung-Do;
Yoon, Hyuk;
Shin, Cheol Min;
Park, Young Soo;
Kim, Nayoung

Publication type:

journal article

A growing link-what is the role of height in cancer risk?

Published in:

2019

By:

Giovannucci, Edward

Publication type:

Editorial

A phase 1b/2, open-label, dose-escalation, and dose-confirmation study of eribulin mesilate in combination with capecitabine.

Published in:

2019

By:

Twelves, Chris;
Anthoney, Alan;
Savulsky, Claudio I.;
Guo, Matthew;
Reyderman, Larisa;
Cresti, Nicola;
Semiglazov, Vladimir;
Timcheva, Constanta;
Zubairi, Ishtiaq;
Morrison, Rosemary;
Plummer, Ruth;
Evans, T. R. Jeffry

Publication type:

journal article